Needle-Free IV Connectors Market Size, Share, Industry, Forecast and outlook (2024-2031)

Needle-Free IV Connectors Market is segmented By Design Type (Simple Connectors, Complex Connectors), By Mechanism (Positive Fluid Displacement Connectors, Negative Fluid Displacement Connectors, Neutral Fluid Displacement Connectors), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

Needle-Free IV Connectors Market Size

 Needle-Free IV Connectors Market size was valued around US$ YY million in 2021 and is estimated to reach US$ YY million by 2031, growing at a CAGR of 9.4% during the forecast period (2024-2031).Competitive rivalry intensifies with CareFusion Corporation, Baxter International Inc., B. Braun Melsungen AG, Vygon SA, Cardinal Health, ICU Medical Inc., and others operating in the market.

Intravenous (IV) access and drug administration are necessary but risky procedures with several possible complications during and post-IV access. The role of Needle-free IV connectors is to reduce the risk of most severe complications and aid in patient compliance. Needle-free IV connectors connect syringes, administration sets, and IV catheters. The application of using needle-free IV connectors, apart from infusion, is to reduce the risk of needle-stick injuries among healthcare providers and reduce the risk of bacterial and microbial contamination.

Needle-free IV connectors market study analysis offers an in-depth outlook on the market containing quantitative and qualitative data. It gives an outlook and forecast of the global market based on market segmentation. It also provides global Needle-free IV connectors market size, and growth, along with the latest trends, opportunities, and forecast till 2029 for the global market with esteem to major countries such as the United States, Canada, Brazil, Germany, Italy, Spain, United Kingdom, Russia, European countries, United Arab Emirates, Saudi Arabia, South Africa, Japan, China, India, South Korea, Australia, and rest of the countries over the globe.

Among all regions, the North American region is expected to hold the largest share of the global market over the forecast period. The Needle-free IV connectors market in the United States and Canada produces the utmost share. Whereas the European Needle-free IV connectors market is projected to continue its presence globally during the period of 2024- 2031.

Needle-Free IV Connectors Market Summary

For More Insights Request Free Sample

Needle-Free IV Connectors Market Dynamics

The global needle-free IV connectors market is primarily driven by the growing risk of life-threatening diseases associated with bloodstream infections and the increasing prevalence of various chronic diseases.

Rising standards for anti-reflux technology in needleless connectors are expected to drive market growth.

According to Nexus Medical, manufacturers of the Nexus TKO-6P Anti-Reflux connector, the Infusion Nurses Society (INS) provided guidance on the use of needleless connectors with anti-reflux technology in its recently publication under 2021 Infusion Therapy Standards of Practice. The updated Standards, INS' most well-known publication, define specific categories of needleless connector technology based on the device's internal mechanism for fluid displacement, negative displacement, positive displacement, neutral, and anti-reflux. Anti-reflux needleless connectors cause the least amount of blood reflux, which can be associated with various catheter-related complications that endanger patient safety, such as catheter failure, intraluminal thrombotic occlusions, and even infections. For instance, The Nexus TKO anti-reflux connector showcases a pressure-activated diaphragm that controls fluid movement, eliminating unintentional blood reflux caused by internal and external pressure changes. It has been shown to produce the least amount of blood reflux compared to any other needleless connector.

Moreover, the Nexus TKO prevents blood reflux while reducing variation and simplifying the complexity of IV therapy. Most needleless connectors require specific flushing, clamping, and disconnection sequences to minimize blood reflux. In comparison, the Nexus TKO's automatically provides bidirectional flow control, preventing blood reflux due to sudden pressure changes and eliminating the need for user-dependent clamping sequences. Thus, from the above-mentioned factor, the market is expected to drive in the forecast period.

Increasing product recalls for needle-free IV connectors are expected to hamper the market growth.

For instance, on January 9, 2020, FDA recalled Baxter Healthcare Corporation's Class 2 Device ONELINK Needle-free IV Connector because its Continu-Flo sets with male Luer bodies at the lower end of, and within, the ISO specification for outer diameter require a greater than expected connection force to fully inset and securely tighten the Luer to the ONE-LINK connector. The manufacturer has initiated the recall, but only some products have been removed and modified. Thus, from the above-mentioned factors, the market is expected to hamper the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic has negatively impacted the needle-free IV connectors market. The COVID-19 pandemic has significantly increased hospital workloads worldwide, and many patients have required extended hospital stays, including admissions to intensive care units (ICUs). Care for these patients was provided under difficult circumstances, not only due to increased workload but also because there was sometimes a need to involve staff with inadequate training with ICU patients. Moreover, catheter-related bloodstream infection can result from bacterial contamination of intravascular catheter infusion hubs in the critically ill. Intravascular catheter entry ports are frequently contaminated with bacteria before bloodstream infections occur. Such contaminations occur during the connection of intravascular line connectors for infusions, drug injections, or blood sample withdrawal. Because of the increased frequency of infusion connections and disconnections, multivolume catheters are especially vulnerable to infection. Therefore, it has been proposed that needle-free connectors (NFC) reduce the rate of bacterial contamination and subsequent catheter-related bloodstream infection (CRBSI).

In contrast, market players have reduced investment in raw materials and resources owing to the closure of manufacturing facilities to protect workers in all regions. Thus, from the above-mentioned factors, the market got affected. However, the situation is expected to improve gradually in the forecast period.

Needle-Free IV Connectors Market Segment Analysis

Neutral fluid displacement connectors segment is expected to hold the largest market share in needle-free IV connectors

The neutral fluid displacement connectors segment accounted for the largest market share in 2021. The segment benefits from having a smooth septum surface with a swabable top that can be thoroughly disinfected, a tight seal between septum and housing, a straight, non-tortuous fluid path, a minimum residual volume, and a clear housing to visualize flushing. For instance, B. Braun Medical Inc., InVision-Plus Neutral Displacement Needleless Connectors with Neutral Advantage Technology are designed to inhibit the migration of bacteria into the fluid pathway, potentially improving patient outcomes and enhancing clinician safety. It is a neutral fluid displacement needleless IV connector that combines septum seal integrity and a double microbial barrier. It has a simple internal cannula design with no moving parts within the fluid pathway. Thus, from the above factors, the market segment accounted for the largest market share in the forecast period.

Needle-Free IV Connectors Market Geographical Share

North America region holds the largest market share in the global needle-Free IV connectors  

North America region is accounted for the largest market share in 2021. The increasing prevalence of Healthcare-associated catheter-related bloodstream infections (HA-BSIs), awareness about the use of needle-free IV connectors among people, the rising geriatric population and the presence of key players in the region are the factors to drive the market in the forecast period. For instance, according to the National Library of Medicine Report 2022, an estimated 250,000 bloodstream infections occur each year, most related to intravascular devices. The CLABSI rate in intensive care units (ICU) in the US is estimated to be 0.8 per 1000 central line days. Therefore, there is an increase in the demand for needle-free IV connectors in the region. Moreover, On May 1, 2019, B. Braun signed a distribution agreement with Nexus Medical, LLC for its Nexus TKO-6P Luer Activated Anti-Reflux Device in the US. Thus, from the above-mentioned factors, the North America region is accounted for the largest market share in the forecast period.

Needle-Free IV Connectors Market Key Players

Major key players in the needle-free IV connectors market are BD, CareFusion Corporation, Baxter International Inc., B. Braun Melsungen AG, Vygon SA, Cardinal Health, ICU Medical Inc., Nexus Medical LLC, RyMed Technologies LLC, and NP Medical Inc.      

BD:

Overview:

Becton, Dickinson and Company (BD) is a global medical technology company that manufactures, and sells various devices, laboratory equipment, medical supplies, and diagnostic products. The business is divided into three divisions: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment manufactures a wide range of medical technologies and devices to help improve healthcare delivery in various settings. BD Medical comprises several business units, such as medication delivery solutions, medication management solutions, diabetes care, and pharmaceutical systems. The BD Life Sciences segment offers products for the collection and transportation of blood specimens and instruments and reagent systems for detecting various infectious diseases, healthcare-associated infections, and cancers. Moreover, the company is serving in more than 190+ countries.

­Product Portfolio:

BD Q-Syte needle-free connector: The BD Q-Syte luer access split septum has a simple internal design with a straight, open fluid path for high-flow rate clinical practice needs.

The global needle-free IV connectors market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.